Type 1 diabetes is a chronic autoimmune condition in which the body’s immune system destroys the cells in the pancreas that produce insulin. About 9 million people worldwide live with it, including over 1.5 million children. Without insulin, blood sugar builds up in the bloodstream instead of entering cells for energy, causing damage throughout the body over time.
What Happens Inside the Body
Your pancreas contains clusters of cells called beta cells, which are responsible for making insulin. In type 1 diabetes, certain immune cells called T cells mistakenly identify these beta cells as threats and attack them. This destruction unfolds over months or years, often silently, before symptoms appear. By the time most people are diagnosed, a large portion of their beta cells have already been destroyed.
Insulin acts like a key that unlocks your cells so they can absorb glucose from your blood. Without enough insulin, glucose stays trapped in the bloodstream. Your cells starve for energy while your blood sugar climbs dangerously high. This is fundamentally different from type 2 diabetes, where the body still makes insulin but doesn’t use it efficiently.
Who Gets It and Why
Most diagnoses happen in childhood or early adulthood, with two distinct peaks: one between ages 4 and 7, and another between 10 and 14. That said, type 1 diabetes can develop at any age. In 2024, over 500,000 new cases were diagnosed globally, and the number is rising each year.
Genetics play a major role. Specific gene variations in the immune system account for roughly 50% of the genetic risk. The highest-risk genetic profile involves carrying two particular gene variants (known as HLA-DR3 and HLA-DR4), which are found more frequently in people diagnosed at the youngest ages. But genetics alone don’t explain everything. Having a high-risk gene profile doesn’t guarantee you’ll develop the condition, and some people who develop it don’t carry the known risk genes. Environmental triggers, possibly viral infections or other factors, are thought to set the autoimmune process in motion in genetically susceptible people.
Symptoms and How They Appear
In its earliest stages, type 1 diabetes causes no symptoms at all. The immune attack on beta cells can be underway for months or years before the body loses enough insulin production to cause problems. When symptoms do appear, they tend to come on fast, sometimes within just a few weeks. The hallmark signs are:
- Excessive thirst and frequent urination: your kidneys work overtime to flush out excess blood sugar
- Unexplained weight loss: without insulin, your body breaks down fat and muscle for energy
- Constant hunger: your cells aren’t getting the glucose they need
- Fatigue and blurred vision
Many people, especially children, are not diagnosed until they develop a dangerous complication called diabetic ketoacidosis (DKA). This happens when the body, starved of insulin, breaks down fat so rapidly that it produces acidic compounds called ketones. DKA is defined by blood sugar above 250 mg/dL, high ketone levels, and blood that becomes dangerously acidic. Symptoms include nausea, vomiting, abdominal pain, fruity-smelling breath, and confusion. It is a medical emergency.
How Type 1 Is Diagnosed
Diabetes of any type is confirmed when blood sugar crosses specific thresholds: a fasting blood sugar of 126 mg/dL or higher, an A1C of 6.5% or above (a measure of average blood sugar over the past two to three months), or a blood sugar of 200 mg/dL or higher on a glucose tolerance test or a random blood draw taken alongside classic symptoms.
Distinguishing type 1 from type 2 requires additional testing. Doctors look for autoantibodies, proteins in the blood that signal the immune system is attacking the pancreas. Four autoantibodies are commonly tested: antibodies against insulin itself, against an enzyme called GAD, against a protein called IA-2, and against a zinc transporter called ZnT8. Finding one or more of these autoantibodies in someone with high blood sugar strongly points to type 1.
Another useful test measures C-peptide, a byproduct released when the body makes its own insulin. A C-peptide level below 0.20 nmol/L indicates very little or no insulin production, which is characteristic of type 1. People with type 2 diabetes typically have C-peptide levels of 0.30 nmol/L or higher because their pancreas still produces insulin. Screening for early-stage type 1 (before symptoms develop) is increasingly recognized as valuable. Researchers estimate that around 0.3% of the general population may have detectable autoantibodies, indicating the disease process has started even though they feel fine.
Living With Insulin Therapy
Everyone with type 1 diabetes needs insulin from the day of diagnosis for the rest of their life. The goal is to mimic what a healthy pancreas does naturally: provide a steady background level of insulin throughout the day, with bursts of extra insulin at mealtimes to handle incoming carbohydrates.
Long-acting insulin covers your baseline needs. It starts working about two hours after injection, has no sharp peak, and lasts up to 24 hours. Rapid-acting insulin handles meals: it kicks in within 15 minutes, peaks at about one hour, and wears off in two to four hours. Most people on injections use some combination of these two types, either through multiple daily shots or an insulin pen.
Insulin pumps offer an alternative to injections. These small devices, worn on the body, deliver a continuous trickle of rapid-acting insulin through a tiny tube under the skin. You press a button to deliver extra insulin before meals. The newest generation of pumps goes a step further: they connect to a continuous glucose monitor (a small sensor worn on the skin that reads your blood sugar every few minutes) and use an algorithm to automatically adjust insulin delivery in real time. These hybrid closed-loop systems bring blood sugar closer to normal with less daily effort. In studies of children and teens, these systems kept blood sugar in the target range about 65 to 67% of the time. Users still need to enter meal information and approve boluses, so the system isn’t fully hands-off, but it significantly reduces the mental burden of managing blood sugar overnight and between meals.
Daily Management Beyond Insulin
Insulin is the cornerstone of treatment, but daily management involves much more. People with type 1 diabetes learn to count carbohydrates so they can match their mealtime insulin dose to what they eat. Exercise lowers blood sugar, sometimes unpredictably, so physical activity requires planning, extra snacks, or insulin adjustments. Illness, stress, hormonal changes, and even hot weather can all shift blood sugar in unexpected directions.
Blood sugar monitoring is constant. Whether through finger-prick tests or a continuous glucose monitor, the goal is to keep blood sugar in a target range (typically 70 to 180 mg/dL for most of the day). Too high over time leads to complications in the eyes, kidneys, nerves, and heart. Too low, called hypoglycemia, causes shakiness, confusion, and in severe cases, loss of consciousness. Balancing between these extremes is a daily effort that never fully pauses.
Long-Term Outlook
Type 1 diabetes is a lifelong condition with no cure, but the tools for managing it have improved dramatically. Continuous glucose monitors, automated pump systems, and faster-acting insulins have made it possible to achieve tighter blood sugar control with less guesswork than previous generations faced. People with well-managed type 1 diabetes live full, active lives, though the condition demands ongoing attention and adjustment every single day.
Complications are still a real concern over decades of living with the disease. Consistently elevated blood sugar damages small blood vessels, which can lead to vision loss, kidney disease, and nerve damage in the hands and feet. Cardiovascular risk is also higher. Tight blood sugar control, regular screening, and addressing risk factors like blood pressure and cholesterol all play a role in reducing these risks over time.